Download PDF
Thromb Haemost 1997; 78(01): 457-461
DOI: 10.1055/s-0038-1657569
Genetic determinants of the risk of arterial thrombosis
Schattauer GmbH Stuttgart

Gene-Environment Interaction in the Determination of Levels of Haemostatic Variables Involved in Thrombosis and Fibrinolysis

S E Humphries
1   Cardiovascular Genetics, Dept of Medicine, University College London Medical School, Rayne Institute, London
,
A Panahloo
2   Department of Medicine, Whittington Hospital, London
,
H E Montgomery
3   The Hatter Institute for Cardiovascular Studies, Dept. of Cardiology, University College London Medical School, London, UK
,
F Green
1   Cardiovascular Genetics, Dept of Medicine, University College London Medical School, Rayne Institute, London
,
J Yudkin
2   Department of Medicine, Whittington Hospital, London
› Author Affiliations
Further Information

Publication History

Publication Date:
12 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Roy SN, Mukhopadhyay G, Redman CM. Regulation of fibrinogen assembly. Transfection of HepG2 cells with BB cDNA specifically enhances synthesis of the three component chains of fibrinogen. J Biol Chem 1990; 265: 6389-6393
    PubMedGoogle Scholar
  • 2 Dalmon J, Laurent M, Courtios G. The human b fibrinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6 responsive element. Mol Cell Biol 1993; 13: 1183-1193
    CrossrefPubMedGoogle Scholar
  • 3 Thomas A, Kelleher C, Green F, Meade TW, Humphries SE. Variation in the promoter region of the β-fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers. Thromb Haemost 1991; 65: 487-490
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Conner JM, Fowkes FGR, Wood J, Smith FB, Donnon PT, Lowe GDO. Genetic variation at fibrinogen loci and plasma fibrinogen levels. J Med Genet 1992; 29: 480-482
    PubMedGoogle Scholar
  • 5 Green F, Hamsten A, Blomback M, Humphries S. The role of b-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden. Thromb Haemost 1993; 70: 915-920
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Scarabin PY, Bara L, Ricard S, Poirer O, Cambou JP, Arveiler D, Luc G, Evans AE, Samama MM, Cambien F. Genetic variation at the β-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of mtocardial infarction. The ECTIM Study. Arterios Thromb 1993; 13: 886-891
    PubMedGoogle Scholar
  • 7 Humphries S, Ye S, Talmud P, Bara L, Wilhelmsen L, Tiret L. 1995; European Atherosclerosis Research Study: Genotype at the fibrinogen locus (G-455-A β- gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe: Evidence for gender - genotype - environment interaction. Arterioscler Thromb Vase Biol 15: 96-104
    CrossrefPubMedGoogle Scholar
  • 8 Iso H, Folsom A, Winklemann JC, Koike K, Harada S, Greenberg B, Sato S, Shimamoto T, Lida MKomachi. Polymorphisms of the beta fibrinbogen gene and plasma fibrinogen concentration in Caucasian and Japanese population samples. Thromb Haemost 1995; 73: 106-111
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Heinrich J, Funke H, Rust S, Schulte H, Schonfeld R, Kohler E, Assman G. Impact of polymorphisms in the alpha- and beta-fibrinogen gene on plasma fibrinogen concentrations of coronary heart disease patients. Thromb Res 1995; 77: 209-215
    CrossrefPubMedGoogle Scholar
  • 10 Thomas AE, Kelleher CC, Green F, Humphries SE. Association of genetic variation at the b-fibrinogen gene locus and plasma fibrinogen levels: interaction between allele frequency of the G/A-455polymorphism, age smoking. Clin Genet 1996; 50: 184-190
    PubMedGoogle Scholar
  • 11 Humphries SE, Green F, Thomas A, Montgomery HE, Winder A, Hamsten A, Miller G. Gene-environment interaction in the determination of plasma fibronogen levels. Fibrinolysis. 1996. 10. in press
    Google Scholar
  • 12 Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WR, Haines AP, Stirling Y, Imeson JD, Thompson SG. Hemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2: 533-537
    PubMedGoogle Scholar
  • 13 Lane A, Humphries SE, Green FR. Effect on transcription of two common genetic polymorphism adjacent to the promoter region of the B-fibrinogen gene. Thromb Haemost 1993; 69: 1539
    PubMedGoogle Scholar
  • 14 Thomas A, Lamlum H, Humphries S, Green F. Linkage disequilibrium across the fibrinogen locus as shown by five genetic polymorphisms, G/A-455(HaeIII),C/T -148 (HindIII/AluI), T/G-1689(AvaII), and BelI (b-fibrinogen) and TaqI (a-fibrino- gen), and their detection by PCR. Hum Mutat 1994; 03: 79-81
    CrossrefPubMedGoogle Scholar
  • 15 Montgomery HE, Clarkson P, Nwose OM, Mikalidis DP, Jagroop IA, Dollery C, Moult J, Benhizia F, Deanfield J, Jubb C, World M, McEwan JR, Winder A, Humphries S. The acute rise in serum fibrinogen concentration with exercise is influenced by the G-453-A polymorphism of the beta-fibrinogen gene. - Arterioscler Thromb Vase Biol 1996; 16: 386-391
    CrossrefPubMedGoogle Scholar
  • 16 Haines AP, Howarth D, North WRS, Goldenberg E, Stirling Y, Meade TW, Raftery EB, Craig MWM. Haemostatic variables and outcome of acute myocardial infarction. Thromb Haemost 1983; 50: 800-803
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Dawson S, Henney A. The status of PAI-1 as a risk factor for arterial and thrombotic disease: A review. Atherosclerosis 1992; 95: 195-117
    PubMedGoogle Scholar
  • 18 Hamsten A, Wiman B, de FaireU, Blomback M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator inhibitor in young survivors of myocardial infarction. New Eng J Med 1985; 313: 1557-1563
    CrossrefPubMedGoogle Scholar
  • 19 Emeis J, Kooistra T. Interleukin-1 and lipopolysaccharide induce a fast acting inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells. J Exp Med 1986; 163: 1260-1266
    CrossrefPubMedGoogle Scholar
  • 20 Lund L, Riccio A, Andreasen P, Nielson L, Kristensen P, Lailho M, Saksela O, Blasi F, Dano K. Transforming growth factor- beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts. EMBO J 1987; 06: 1281-1286
    PubMedGoogle Scholar
  • 21 Alessi M, Juhan-Vague I, Kooistra T, Declerck P, Collen D. Insulin stimulates the synthesis of plasminogen activator inhibitor-1 by the human hepatocellular cell line HepG2. Thromb Haemost 1988; 60: 491-494
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Lucore C, Fuji S, Wun T, Sobel B, Billadello J. Regulation of the expression of type 1 plasminogen activator inhibitor in HepG2 cells by epidermal growth factor. J Biol Chem 1988; 263: 15845-15848
    PubMedGoogle Scholar
  • 23 Riccio A, Lund L, Sartorio R, Lania A, Andreasen P, Danf K, Blasi F. The regulatory region of the human plasminogen activator inhibitor type-1 gene. Nucl Acid Res 1988; 16: 2805-2824
    CrossrefPubMedGoogle Scholar
  • 24 Stiko-Rahm A, Wiman B, Hamsten A, Nilsson J. Secretion of plasminogen activator inhibitor-1 from human umbilical vein endothelial cells is induced by very low density lipoprotein. Arteriosclerosis 1990; 10: 1067-1073
    CrossrefPubMedGoogle Scholar
  • 25 De Boer J, Abbnik J, Brouwer M, Meijer C, Roem D, Voorn G, Lanbers J, Van Mourik J, Hark C. PAI-1 synthesis in the human hepatoma cell line HepG2 is increased by cytokines - evidence that the liver contributes to acute phase behaviour of PAI-1. Thromb Haemost 1991; 65: 181-187
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henney A. The two allele sequences of a common polymorphisms in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to IL-1 in HepG2 cells. J Biol Chem 1993; 268: 10739-10745
    PubMedGoogle Scholar
  • 27 Eriksson P, Kallin B, Van’t Hooft FM, Bavenholm P, Hamsten A. Allele specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Nat Acad Sci USA 1995; 92: 1851-1855
    CrossrefPubMedGoogle Scholar
  • 28 Ye S, Green FR, Scarabin PY, Nicaud V, Bara L, Dawson SJ, Humphries SE, Evans A, Luc G, Cambou JP, Arveiler D, Henney AM, Cambien F. (1995) The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Thromb Haemost 74 (03) 837-841
    PubMedGoogle Scholar
  • 29 Mansfield MW, Stickland MH, Grant PL. Plasminongen activator inhibitor-1 (PAI-1) promoter polymorphism and coromary artery dsiease in non-insulin-dependent diabetes. Thromb Haemost 1995; 74: 1032-1034
    Article in Thieme ConnectPubMedGoogle Scholar
  • 30 Ossei-Geming N, Mansfield MW, Stickland MH, Wilson JJ, Grant PJ. Plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G genotype and levels in relation to a history of myocardial infarction in patients characterised by coronary angiography. Arterioscler Thromb Vase Biol. 1996 (in press)
    PubMedGoogle Scholar
  • 31 Juhan-Vague I, Alessi MC, Badier C, Valadier J, Ailaud MF, Atlan C. Relationship between plasma insulin, triglyceride, body mass index and plasminogen activator inhibitor-1. Diabete Metab 1987; 13: 331-336
    PubMedGoogle Scholar
  • 32 Juhan-Vague I, Alessi M, Joly P, Thirion X, Vague P, Declerck P, Serrodinugni A, Collen D. Plasma plasminogen activator inhibitor 1 in angina pectoris: Influence of plasma insulin and acute phase response. Arterioscler Thromb 1989; 09: 362-367
    CrossrefPubMedGoogle Scholar
  • 33 Panahloo A, Mohamed-Ali V, Lane A, Green F, Humphries SE, Yudkin JS. Determinants of plasminogen activator inhibitor 1 activity in treated NIDMM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene. Diabetes 1995; 44: 37-42
    CrossrefPubMedGoogle Scholar
  • 34 Mansfield MW, Stickland MH, Grant PL. Environmental and genetic factors in relation to elevated circulating levels of plasminogen activator inhibitor-1 in Caucasian patients with noninsulin dependent diabetes. Thromb Haemost 1995; 74: 842-847
    Article in Thieme ConnectPubMedGoogle Scholar
  • 35 Sironi L, Mussoni L, Prati M, Baldassarre D, Camera M, Banfi C, Tremoli E. Plasminongen activator inhibitor type-1 synthesis and mRNA expression in HepG2 cells are regulated by VLDL. Arterioscler Thromb Vase Biol 1996; 16: 89-96
    CrossrefPubMedGoogle Scholar